MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
Einsatz des DigestPro zur Brustkrebsforschung Lesen sie: MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
7.
Okt.
2020